Form 4 for DRIO DarioHealth Corp.
Accepted 2026-07-28 17:27:53 ET · period of report 2024-08-12 · accession 0001104659-26-087626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-28 17:27 | 2024-08-12 | DRIO | Matheis Dennis | Dir | C - Cnv Deriv | $19.10 | +965 | 28.6K | +3% | +$18.4K |
| D | 2026-07-28 17:27 | 2026-07-23 | DRIO | Matheis Dennis | Dir | P - Purchase | $6.93 | +14.4K | 43.0K | +50% | +$100.0K |
| D | 2026-07-28 17:27 | 2024-08-12 | DRIO | Matheis Dennis | Dir | C - Cnv Deriv | $1,000.00 | -50 | 0 | -100% | -$50.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-12 | C | A | 965 | $19.10 | 28,596 | D | — | — | (F1) Pursuant to its terms, the Series B Preferred Stock automatically converted into shares of common stock, subject to certain beneficial ownership limitations, including a non-waivable 19.99% ownership blocker, on the 15-month anniversary of the issuance date. (F2) The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion. (F2) The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion. (F2) The Reporting Person's 50 shares of Series B-2 Preferred Stock automatically converted into 19,289 shares of Common Stock on August 12, 2024. Following the Issuer's subsequent reverse stock split, the conversion shares are reported as 965 shares of Common Stock. The Reporting Person also received shares of Common Stock pursuant to the dividend provisions applicable to the Series B Preferred Stock. After giving effect to the reverse stock split and such dividend shares, the Reporting Person beneficially owned 28,596 shares of Common Stock immediately following the conversion. |
| 2 | Common | Common Stock | 2026-07-23 | P | A | 14,430 | $6.93 | 43,026 | D | — | — | (F3) The reported shares were acquired pursuant to a Securities Purchase Agreement with the issuer, dated July 22, 2026, at a purchase price of $6.93 per share. |
| 3 | Derivative | Series B-2 Preferred Stock | 2024-08-12 | C | D | 50 | $1,000.00 | 0 | D | $1,000.00 · 2023-05-04 to 2024-08-04 | 965 Common Stock |